Insiders Put the Petal to the Metal as Animal Spirits Show Signs of Life

Animal spirits are picking up.  This is the most buying we've seen since the market sell-off last December. One thing for sure, Insiders buy stocks when they think they are cheap.  Highlights are:…


Enercom Day 2 Misery Loves Company

Keynote Day 2 was an unconventional presentation from the unconventional wildcatter Harold Hamm and Tom Petrie, storied oil analyst.  Never been more pressure to cut production Harold Hamms said. I…


Blood on the Streets in Denver Enercom notes day 1 hashtag #freecashflow

Occidental's Cashless Bet the Farm Collar on the Anadarko Deal The old adage is you make money when you wait to buy when there is blood on the streets. There is certainly some blood on the streets in…


It's Getting Interesting- Insider Buying Picks Up Week Ending 8-9-19

After weeks of dull action, insider buying has finally picked up. Part of it is the end of 2nd Quarter earnings blackout and part of it is the market sell-off.  The highlights: Charlie Egren, the…


Stock Market gets Clobbered - 4 Insiders buy over $6 million of Pharma Giant AbbVie $ABBV

Another dull week for insider buying but not the market. Markets have the worst week of the year.  This hardly comes as a surprise as insiders are an endangered species, the lowest ratio of buying on…


Trump needs the Farmers more specifically the Farm States in 2020 Buy Archer Daniel Midland $ADM

It's no secret Trump loves the farmers. It's also no secret his trade war with China is killing them too. That's why we are buying Archer Daniels Midland.  Bioethanol, corn and the feedstocks for it…


Insider Buying is Anemic- BUT WE STILL FIND SOMETHING TO BUY $APD,$CCI,$URI

Insider Buying is Anemic- Insider Buying is Anemic- BUT WE STILL FIND SOMETHING TO BUY $APD,$CCI,$URI -try these names on for size Week Ending 7-26-19 Two large-cap buyers have excellent track…


Eyenovia merits a closer look $EVEN

CEO Ianchulev purchase of microcap Eyenovia merits a closer look. This was part of a spot 4.38 M share spot secondary at $2.78. Eyenovia is marketing a high tech eyedropper.  The 100-year-old…


Biotech and Big Pharma Dominate this Week's Insider Buys

Odonate ODT's Chairman and CEO Kevin Tang has made open market purchases of more than $36 million in so far this June, including $10 million on the spot secondary at the highest price his paid all…


We took money off the table today in a bad tape with a good trade on Biogen

Biogen spiked handsomely today and we took money off the table in a bad tape. We wrote on May 4th, that we were particularly excited about Biogen. Two insiders had bought material amounts of stock…